GENE ONLINE|News &
Opinion
Blog

2026-06-29|

Methanex Indefinitely Idles 850,000-Tonne Titan Methanol Plant in Trinidad and Tobago

by GOAI
Share To

Methanex Corporation announced on Monday that it will indefinitely idle its Titan methanol production facility in Trinidad and Tobago, effective immediately. The company cited ongoing natural gas supply constraints in the region as the primary reason for the decision, noting that the move aligns with its strategy to manage global production capacity in response to feedstock availability.

The Titan plant, which has a production capacity of 850,000 tonnes per year, will remain in a state of indefinite suspension until further notice. Methanex stated that it continues to operate its other facilities in Trinidad and Tobago, including the Atlas and Methanex Chile-linked operations, as gas supply permits. The company is currently working with its natural gas suppliers and local stakeholders to navigate the supply challenges affecting the region’s industrial sector. This operational adjustment follows a broader trend of production management across the company’s global portfolio as it balances market demand with regional resource limitations.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 29, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Codon-Pair Deoptimization Attenuates FMDV in Swine but Fails to Induce Protective Immunity
2026-07-16
Grady Emerson and Maddie DiMaria Named 2025-2026 Gatorade National Players of the Year
2026-07-15
Longitudinal Network Analysis Tracks Evolving Symptom Clusters in Elderly Chronic Gastritis Patients
2026-07-15
Taiwan Study Finds Allergic Disease Multimorbidity Patterns Shift During Elementary School Years
2026-07-15
NHS Data Shows 30-Fold Disparity in Specialty Training Success Rates Between Ethnic Groups
2026-07-15
New Jersey Meteorite Confirmed to Contain Extraterrestrial Chemical Signatures
2026-07-15
Vanda Pharmaceuticals Sponsors No. 47 IndyCar to Mark 47-Year Gap in Motion Sickness Treatments
2026-07-15
Scroll to Top